Neuro Biomarkers

A biomarker is a characteristic, that is, objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacologic responses to a therapeutic intervention. There are several features that are desirable for biomarkers to be useful in the Neurocritical Care Unit (NICU). They must be brain specific; they must increase or decrease significantly during the relevant neurological insult; they must be available within a few hours. All these features will help a treating physician to make better diagnosis and direct care.

  • Drug Development using Biomarkers
  • Cerebrospinal Fluid Biomarkers
  • Molecular and Neuroimaging Biomarkers
  • Safety Biomarkers

Related Conference of Neuro Biomarkers

July 20-21, 2026

37th World Congress on Neurology and Neuroscience

Amsterdam, Netherlands
July 23-24, 2026

14th International Conference on Cannabis & Medicinal Research

Amsterdam, Netherlands
September 18-19, 2026

21st Annual Congress on Neuroscience

Dubai, UAE
November 16-17, 2026

8th World Brain Congress

Tokyo, Japan
November 23-24, 2026

16th Global Alzheimers Summit

Paris, France
November 24-25, 2026

38th World Conference on Neurology

Rome, Italy
December 16-17, 2026

12th International Conference on Brain Injury & Neuro Surgeons

Amsterdam, Netherlands
December 21-22, 2026

6th International Conference on Child Neurology

Paris, France
December 28-29, 2026

39th European Neurology Congress

Amsterdam, Netherlands
December 28-29, 2026

18th Global Neurologists Meeting on Neurology and Neurosurgery

Amsterdam, Netherlands
March 22-23, 2027

8th International Conference on Neurologists

Singapore City, Singapore

Neuro Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in